Pharma Digests

Forum Replies Created

Viewing 15 posts - 31 through 45 (of 50 total)
  • Author
    Posts
  • in reply to: QMS Tools #6109
    Pharma Digests
    Pharma Expert

      @frd

      1) production
      2) facilities and equipment
      3) laboratory controls
      4) materials
      5) packaging and labeling
      6) quality management

      • This reply was modified 1 year, 8 months ago by .
      in reply to: FBP Process Scale-Up #6096
      Pharma Digests
      Pharma Expert

        Following FBP parameters you can remain same/similar in both R&D and Production scale:
        – Inlet air temperature
        – Product temperature
        – Atomization nozzle size

        And you should adjust the below parameters:
        – Inlet air flow
        – Spray rate
        – Atomization air pressure

        in reply to: Imprinting of Solid Oral Dosage Form #6095
        Pharma Digests
        Pharma Expert

          Yes, FDA requires for any solid dosage drug products of prescription or OTC be it tablets or capsules to have imprint code for product identification and to prevent fraud.

          in reply to: Imprinting of Solid Oral Dosage Form #6087
          Pharma Digests
          Pharma Expert

            – It should be a unique identification of the drug product and the manufacturer or distributor of the product.
            – It can be any single letter or number or any combination of letters and numbers.
            – This is applicable for solid oral dosage form drug product.

            • This reply was modified 1 year, 9 months ago by .
            in reply to: FBP Process Scale-Up #6085
            Pharma Digests
            Pharma Expert

              You can follow the below equation-
              A = πr^2

              Where,
              A= cross sectional surface area (m^2)
              r= radious of the bottom screen (m)

              in reply to: azithromycin bcs #6019
              Pharma Digests
              Pharma Expert

                As per clinical pharmacology and biopharmaceutics review of Zithromax, Azithromycin fall in BCS class I or III.

                Ref.: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/50-784_zithromax_biopharmr.pdf

                in reply to: Valsartan + Amlodipine Tablets #5971
                Pharma Digests
                Pharma Expert

                  @FRD
                  As far I know there is no major challenges in analytical method of Valsartan + Amlodipine Tablets. You can follow USP method.

                  in reply to: Pharmaceutical Development – ICH Q8 (R2) #5968
                  Pharma Digests
                  Pharma Expert

                    @FRD
                    This guideline is a basement of QbD approach. But there is a lot of guidelines and practical courses are available now.

                    in reply to: Valsartan + Amlodipine Tablets #5907
                    Pharma Digests
                    Pharma Expert

                      Roller compaction or slugging process is better for manufacturing of Valsartan + Amlodipine Tablets.

                      in reply to: Biowaiver #5681
                      Pharma Digests
                      Pharma Expert

                        Nicely explained @aid.

                        Can you share any authentic source of BCS database?

                        • This reply was modified 2 years, 2 months ago by .
                        in reply to: GMP Cheklist #5676
                        Pharma Digests
                        Pharma Expert

                          Bekow things should also include for a new GMP facility:
                          – Records and Reports
                          – Sanitation condition
                          – HVAC system
                          – Raw material sourcing
                          – Internal audit and compliance etc.

                          in reply to: Most Stringent Regulatory Authorities #5469
                          Pharma Digests
                          Pharma Expert

                            Here is the list of most stringent regulatory authorities:
                            1. US FDA
                            2. EMA (European Union)
                            3. ANVISA (Brazil)
                            4. Health Canada
                            5. TGA (Australia)
                            6. PMDA (Japan)
                            7. SAHPRA (South Africa)
                            8. NPRA (Malaysia)
                            9. NPMA (China)
                            10. HSA (Singapore)

                            It may slightly vary based on the cGMP practice and clinical study requirements.

                            • This reply was modified 1 year, 8 months ago by .
                            in reply to: Community Pharmacist vs Retail Pharmacist #4694
                            Pharma Digests
                            Pharma Expert

                              Very similar.
                              – Community pharmacists supply prescribed and over-the-counter medicines to the general public.
                              – Retail pharmacists fill medication orders placed by doctors for customers who come into their pharmacy.

                              in reply to: QMS Tools #4693
                              Pharma Digests
                              Pharma Expert

                                – AssurX
                                – Veeva
                                – Intellect QMS
                                – ISOXpress
                                – Qualio etc.

                                in reply to: FDA Guideline for Data Integrity #4692
                                Pharma Digests
                                Pharma Expert

                                  Requirements with respect to data integrity in 21 CFR parts 11, 211 and 212:
                                  – 21 CFR PART 211.68
                                  – 21 CFR PART 211.100
                                  – 21 CFR PART 211.160
                                  – 21 CFR PART 211.180
                                  – 21 CFR PART 211.188
                                  – 21 CFR PART 211.194
                                  – 21 CFR PART 212.110
                                  – 21 CFR PART 212.60
                                  – 21 CFR part 11

                                Viewing 15 posts - 31 through 45 (of 50 total)